Second primary malignancies in patients with cancer of the head and neck

Abstract

OBJECTIVE: Clinical study of second primary malignancies (SPM) in patients with cancer of the head and neck (HNC).

STUDY DESIGN AND SETTING: Retrospective study over 48 patients with SPMs culled from 636 with HNC seen in 122 months. The minimum follow-up was 18 months, and the setting for the study was the institutional referral center.

RESULTS: There was association between the sites of first and second tumor. The SPMs were diagnosed with a constant rate throughout the period of study. Five year-survival rate was 29%. SPM in an advanced stage either outside of the head and neck or synchronous had poor survival.

CONCLUSION: The SPMs are a growing problem with better survival after treatment of the first malignancy.

SIGNIFICANCE: Regular follow-up is necessary in HNC patients to improve their survival, giving special attention to the development of SPM.

Get full access to this article

View all access options for this article.

References

Cooney

Poulsen

Is routine follow-up useful after combined-modality therapy for advanced head and neck cancer?

Arch Otolaryngol Head Neck Surg 1999; 125:379–82.

Schwartz

Ozsahin

Zhang

Synchronous and metachronous head and neck carcinomas. Cancer 1994; 74:1933–8.

Dhooge

De Vos

Van Cauwenberge

Multiple primary malignant tumors in patients with head and neck cancer: results of a prospective study and future perspectives. Laryngoscope 1998; 108:250–6.

DMC

A study of the behavior of cancer of the head and neck during its late and terminal phases. Am J Surg 1964; 108:552–7.

Sood

Bradley

Quraishi

Second primary tumors in squamous cell carcinoma of the head and neck: incidence, site, location, and prevention. Curr Opin Otolaryngol Head Neck Surg 2000; 8:87–90.

Panosetti

Luboinski

Mamelle

Multiple synchronous and metachronous cancers of the upper aerodigestive tract: a nine-year study. Laryngoscope 1989; 99:1267–73.

Moertel

Incidence and significance of multiple primary malignant neoplasms. Ann N Y Acad Sci 1964; 114:886–95.

Warren

Gates

Multiple malignant tumors: a survey of literature and statistical study. Am J Cancer 1932; 51:1358–414.

De Vergas Gutierrez

Brandariz Castelo

Galván Parrado

Segundos tumores primarios en pacientes con carcinoma faringolaríngeo. Acta Otorrinolaring Esp 1998; 49:459–64.

10.

Choy

ATK

van Hasselt

Chisholm

Multiple primary cancers in Hong Kong Chinese patients with squamous cell cancer of the head or neck. Cancer 1992; 70:815–20.

11.

Albright

Karpati

Topham

Second malignant neoplasms in patients under 40 years of age with laryngeal cancer. Laryngoscope 2001; 111:563–567.

12.

Slaughter

Southwick

Smejkal

“Field cancerization” in oral stratified squamous epithelium. Cancer 1953; 6:963–8.

13.

Lydiatt

Anderson

Bazzana

Molecular support for field cancerization in the head and neck. Cancer 1998; 82:1376–80.

14.

Day

Blot

Shore

Second cancers following oral and pharyngeal cancers: role of tobacco and alcohol. J Natl Cancer Inst 1994; 86:131–7.

15.

Sturgis

Miller

Second primary malignancies in the head and neck cancer patient. Ann Otol Rhinol Laryngol 1995; 104:946–54.

16.

Haughey

Gates

Arfken

Meta-analysis of second malignant tumors in head and neck cancer: the case for endoscopic screening protocol. Ann Otol Rhinol Laryngol 1992; 101:105–12.

17.

Dolan

Vaughan

Fuleihan

Metachronous cancer: prognostic factors including prior irradiation. Otolaryngol Head Neck Surg 1998; 119:619–23.

18.

Robinson

Neugut

Murray

A comparison of the clinical characteristics of first and second primary head and neck cancers. Cancer 1991; 68:189–92.

19.

Black

Gluckman

Shumrick

Multiple primary tumours of the upper aerodigestive tract. Clin Otolaryngol 1983; 8:277–81.

20.

Boysen

Lovdal

Tausjo

The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. Eur J Cancer 1992; 28:426–30.